Arhive autor: INVL

INVL Private Equity Fund II, IFC, ACP back POLMED’s expansion in cancer care

A consortium of the INVL Private Equity Fund II, one of the largest private equity funds in Central and Eastern Europe, the International Finance Corporation (IFC), and Accession Capital Partners (ACP) has completed an investment in POLMED, one of Poland’s largest healthcare groups. POLMED is using the proceeds to acquire the KN Group, an operator of oncology centers.

“As new strategic partners of POLMED, we are embarking on an ambitious expansion with them. The acquisition of the KN Group immediately strengthens the group’s expertise and market position in oncology. We aim to create Poland’s premier healthcare provider, one that is modern and accessible all across the country. For patients, this will translate into the highest quality of care and a broad spectrum of diagnostic services,” says Luke Staniczek, the Investments Lead in Poland at the INVL Private Equity Fund II.

“We believe that the expansion of POLMED will further strengthen its ability to provide the highest-quality services to its patients, whose health and well-being remain top priority for us,” adds Nerijus Drobavičius, a Partner at the INVL Private Equity Fund II.

Following the consortium’s investment, the majority stake in POLMED continues to be held by the group’s Founder and President, Radosław Szubert, together with Co-founder and Vice-President Romuald Magdoń, while the INVL PrivateEquityFund II, theIFC and ACP each hold significant minority stakes.

Founded in 1999, POLMED has grown into one of Poland’s largest private healthcare service groups, with revenue in 2024 exceeding EUR 100 million. The company provides outpatient care, diagnostic imaging, and inpatient and home rehabilitation services. With 38 facilities of its own, including 380 hospital beds and a team of approximately 2,000 employees, it also collaborates with more than 4,000 medical partners across Poland, serving more than 4 million patients annually and providing services to over 3,500 companies.

The KN Group operates three oncology centers in Radom and Warsaw: the Radom Oncology Center, the Gamma Knife Centre, and the Radom Family Center, with combined 2024 revenues of EUR 54.5 million. The group employs over 700 peopleand has approximately 150 beds, including 14 chemotherapy chairs. It is led by the internationally renowned neurosurgeon Prof. Mirosław Ząbek and Managing Director Dorota Ząbek, both of whom will continue in their roles within the company.

POLMED marks the second investment completed by the INVL Private Equity Fund II, which announced its final closing earlier this year at EUR 410 million, above the hardcap. The fund is in its active investment phase.It is targeting companies with enterprise values of EUR 30 million to EUR 200 million or more across Baltics, Poland, Romania and the broader EU.

 

About the INVL Private Equity Fund II

With EUR 410 million of commitments, this is the largest private equity fund in the Baltics and one of the largest in Central and Eastern Europe. The fund is sector-agnostic and is looking to build a diversified portfolio investing in companies with the potential to become regional leaders in their respective industries. Equity tickets range between EUR 10 million and EUR 60 million, though larger ticketsare possible with co-investors. The fund is seeking majority or significant minority stakes where it could drive long-term value creation. The focus is on businesses with strong potential to grow and compete amid intensifying global competition. Geographically, the fund is targeting opportunities in the Baltic countries, Poland, and the broader Europe Union.

The fund is managed by INVL Asset Management, the leading Baltic alternative asset manager, which is a part of the Invalda INVL Group with over 30 years of experience. The group’s companies more than EUR 2 billion in assets under management or supervision across various investment strategies, including private equity, forests and agricultural land, renewable energy, real estate, and private debt. Additionally, the group provides family office services in Lithuania, Latvia and Estonia, manages pension funds in Latvia, and invests in global third-party funds.

 

About IFC

IFC — a member of the World Bank Group — is the largest global development institution focused on the private sector in emerging markets. We work in more than 100 countries, using our capital, expertise, and influence to create markets and opportunities in developing countries. In fiscal year 2025, IFC committed a record $71.7 billion to private companies and financial institutions in developing countries, leveraging private sector solutions and mobilizing private capital to create a world free of poverty on a livable planet. For more information, visit www.ifc.org.

 

About the Accession Capital Partners (ACP)

Accession Capital Partners (ACP) is investing from its fifth fund, the AMC V SCA SICAV-RAIF, which closed at EUR 336 million in June 2024. ACP has been operating in Central Europe since the year 2000 through its offices in Vienna, Warsaw, Bucharest, Budapest and Prague. To date, the group has raised commitments of more than EUR 1.2 billion in five dedicated growth capital funds. The funds are backed by reputable institutional investors, including the European Investment Fund, the International Finance Corporation, the European Bank for Reconstruction and Development and a number of banks, family offices, funds of funds, pension funds and insurance companies from Europe, the US and Asia.

 

 

Important information

This is a marketing communication of an information nature, which is not and shall not be construed as an offer to purchase investment units of a collective investment undertaking, an investment recommendation, or investment research, as it is not designed to take into account the investment objectives, financial situation, or needs of any individual investor.

When investing, the investors assume the risk associated with the investment. The value of investments can both rise and fall, and investors may recover less than they invested. Past investment results do not guarantee the same results or profitability in the future. Past performance is not a reliable indicator of future performance. Before making a decision to invest, potential investors should, on their own or with the help of investment advisers, assess the suitability of the investment for them along with the taxes and fees related to the investment, consider all the risks related to the investment, and carefully read the rules, prospectus and other documents of the respective collective investment undertaking.

Units of the collective investment undertaking mentioned in this press release may only be distributed to informed investors as defined in the Law on Collective Investment Undertakings for Informed Investors of the Republic of Lithuania, as amended and supplemented from time to time, and may not be distributed or transferred to any other clients.

INVL Baltic Sea Growth Fund exits MBL as MidEuropa acquires majority stake

The INVL Baltic Sea Growth Fund, the leading private equity fund in the Baltics, has sold its entire stake in the MBL Group to the private equity investor MidEuropa.

MBL is a leading European contract development and manufacturing organisation (CDMO) for assisted mobility, rehabilitation and aged-care equipment. The founding Lauritsen family has reinvested a significant amount, and Martin Lauritsen will continue to lead the company as CEO, the transaction participants announced. The exit,the second for the INVL Baltic Sea Growth Fund, already enables full repayment of the fund to investors.

Nerijus Drobavičius, a Partner at the INVL Baltic Sea Growth Fund, commented: “We invested in MBL back in mid-2020, during the first Covid wave, as we saw large potential in the company. We have been excited to see the company’s EBITDA almost triple since we invested. We greatly appreciate the Lauritsen family’s ability to combine customer empathy with engineering excellence to create products that genuinely improve lives. MBL has become a world-class CDMO and we are confident it will continue to thrive with its new partners.”

Ashwin Roy, a Non-Executive Partner at the INVL Baltic Sea Growth Fund, added: “We are proud to have supported MBL through a challenging macroeconomic environment, from which it has emerged as a clear category leader with enhanced innovation capabilities and a strong platform for further success.”

Founded by the Lauritsen family in Denmark in 1988, MBL is the largest European CDMO for medical mobility devices, including wheelchair components, rollators, power add-on devices, and other rehabilitation equipment. With deep expertise in both individual component manufacturing and complete mobility solutions, MBL has built a highly differentiated, fully integrated platform combining in-house R&D, state-of-the-art manufacturing and industry-leading reliability. The company employs approximately 1,700 skilled professionals across manufacturing hubs in Europe and Asia, serving global blue-chip clients. With more than 100 registered patents, it is highly regarded for its innovation capabilities. MBL’s revenue in 2025is expected to exceed EUR 120 million.

Martin Lauritsen, the CEO of MBL, commented: “MBL has had the privilege of working with theInvalda INVL Group over the past several years and is now excited to welcome MidEuropa. We see this transaction as a strong endorsement of our business model and long-term potential. With the continued commitment of our family, we are excited to enter the next phase of international growth, building on our position as the leading European CDMO in assisted mobility and rehabilitation. Most importantly, we will continue to strengthen our partnerships with customers, developing innovative solutions that improve quality of life for the people who rely on our products every day.”

Rustam Kurmakaev, Principal at MidEuropa, who led the transaction, said: “We are impressed by what the Lauritsen family has achieved in creating a fully integrated international platform. We look forward to supporting Martin and his team as they further strengthen MBL’s offering and continue the company’s journey towards becoming a global leader in its field. The assisted mobility market is set for sustained growth, driven by population ageing, rising prevalence of chronic conditions and expanding access to mobility solutions worldwide.”

Robert Knorr, Managing Partner at MidEuropa, added: “This investment underscores our continued commitment to backing high-quality healthcare platforms with strong fundamentals, differentiated capabilities and long-term growth potential.”

The transaction was led by Jefferies International as M&A advisor. Also assisting the fund were legal advisors Horten, financial and tax advisors Deloitte, and commercial advisor L.E.K.

 

About the INVL Baltic Sea Growth Fund

With a fund size of EUR 165 million, the INVL Baltic Sea Growth Fund is one of the leading private equity funds in the Baltics. Its anchor investor is the European Investment Fund (EIF), which is a part of the European Investment Bank and committed EUR 30 million with the support of the European Fund for Strategic Investments (a key element of the Investment Plan for Europe, or the Junker Plan) while also allocating resources from the Baltic Innovation Fund (a “fund of funds” initiative developed in cooperation with the governments of Lithuania, Latvia and Estonia,  to increase capital investment in high-growth potential small and medium-sized enterprises in the Baltics). The fund is managed by INVL Asset Management, the leading Baltic alternative asset manager, which is a part of the Invalda INVL Group with over 30 years of experience. The group’s companies manage or have under supervision more than EUR 2 billion in assets across various investment strategies, including private equity, forests and agricultural land, renewable energy, real estate, and private debt. Additionally, the group provides family office services in Lithuania, Latvia and Estonia, manages pension funds in Latvia, and invests in global third-party funds.

 

About MidEuropa

MidEuropa is a leading European private equity investor with deep roots in Central Europe and a track record spanning over 25 years. Headquartered in London, with offices in Warsaw and Bucharest, MidEuropa takes a flexible pan-European and global approach to identify winning investments across the healthcare, technology, services, and consumer sectors, and supports them in their growth and international expansion. To date, MidEuropa has raised and managed funds of over EUR 6.8 billion and completed 46 investments and more than 290 add-on acquisitions across 20 countries. www.mideuropa.com

 

Important information

This is a marketing communication of an informational nature which is not and shall not be construed as an offer to purchase investment units of a collective investment undertaking, an investment recommendation, or investment research, as it is not designed to take into account the investment objectives, financial situation, or needs ofany individual investor.

When investing, the investors assume the risk associated with the investment. The value of investments can both rise and fall, and an investor may recover less than he/she/it has invested. Past investment results do not guarantee the same results or profitability in the future. Past performance is not a reliable indicator of future performance. Before making a decision to invest, potential investors should, on their own or with the help of investment advisers, assess the suitability of the investment for them along with the taxes and fees related to the investment, consider all the risks related to the investment, and carefully read the rules, prospectus and other documents of the respective collective investment undertaking.

Units of the collective investment undertaking mentioned in this press release may only be distributed to professional investors (clients) as defined in the Law on Markets in Financial Instruments of the Republic of Lithuania, as amended and supplemented from time to time, and may not be distributed or transferred to any other clients.